Search Within

David Hyman

  1. "Jaclyn Hechtman"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (18)
  3. Research Letter (1)
Groups
  1. Department of Medicine (45)
  2. Early Drug Development Service (45)
  3. Solid Tumor Oncology Division (45)
  4. GSK Faculty (44)
  5. Department of Pathology and Laboratory Medicine (42)
  6. Human Oncology and Pathogenesis Program (39)

More Groups

People
  1. Jaclyn Hechtman (45)
  2. Marc Ladanyi (28)
  3. Michael Berger (25)
  4. Alexander Drilon (24)
  5. Ahmet Zehir (23)
  6. Ryma Benayed (21)

More People

Years
  1. 2021 (1)
  2. 2020 (7)
  3. 2019 (8)
  4. 2018 (12)
  5. 2017 (10)
  6. 2016 (4)

More Years

Publications
  1. Cancer Research (6)
  2. Clinical Cancer Research (5)
  3. Journal of Clinical Oncology (5)
  4. JCO Precision Oncology (4)
  5. Modern Pathology (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (15)
  2. American Society of Clinical Oncology (9)
  3. Nature Publishing Group (5)
  4. Nature Research (4)
  5. Oxford University Press (3)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TRK XDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Journal Article

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arruabarrena-Aristorena, A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients
    Journal Article

    Ross, D. S.; Liu, B.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Landscape and outcome of TRK fusion-positive cancers
    Meeting Abstract

    Rosen, E. Y.; Goldman, D. A.; Hechtman, J. F.; Benayed, R.; Schram, A. M.; Cocco, E.; Shifman, S.; Gong, Y.; Kundra, R.; Solomon, J. P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK fusions are enriched in cancers with uncommon histologies and the absence of canonical driver mutations
    Journal Article

    Rosen, E. Y.; Goldman, D. A.; Hechtman, J. F.; Benayed, R.; Schram, A. M.; Cocco, E.; Shifman, S.; Gong, Y.; Kundra, R.; Solomon, J. P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Detection of RET kinase fusions using DNA, RNA, and protein-based methods
    Meeting Abstract

    Yang, S. R.; Mata, D.; Benayed, R.; Mullaney, K.; Frosina, D.; Rekhtman, N.; Drilon, A.; Hyman, D.; Ladanyi, M.; Jungbluth, A.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • NTRK fusion detection across multiple assays and 33,997 cases: Diagnostic implications and pitfalls
    Journal Article

    Solomon, J. P.; Linkov, I.; Rosado, A.; Mullaney, K.; Rosen, E. Y.; Frosina, D.; Jungbluth, A. A.; Zehir, A.; Benayed, R.; Drilon, A.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Real-world outcomes of an automated physician support system for genome-driven oncology
    Journal Article

    Tao, J. J.; Eubank, M. H.; Schram, A. M.; Cangemi, N.; Pamer, E.; Rosen, E. Y.; Schultz, N.; Chakravarty, D.; Philip, J.; Hechtman, J. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation
    Meeting Abstract

    Cocco, E.; Kulick, A.; Misale, S.; Yaeger, R.; Razavi, P.; Won, H. H.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; Cownie, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save